CME Group (CME) Scheduled to Post Earnings on Wednesday

CME Group (NASDAQ:CME) will be releasing its Q3 2019 earnings data before the market opens on Wednesday, October 30th. Analysts expect CME Group to post earnings of $1.70 per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.75 by $0.01. The firm had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.27 billion. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The firm’s quarterly revenue was up 20.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.74 earnings per share. On average, analysts expect CME Group to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

CME opened at $200.66 on Tuesday. The stock has a market capitalization of $72.78 billion, a PE ratio of 29.42, a P/E/G ratio of 4.28 and a beta of 0.20. The firm’s fifty day moving average price is $210.59 and its 200 day moving average price is $200.13. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.05 and a quick ratio of 1.05. CME Group has a 12-month low of $161.05 and a 12-month high of $224.91.

Several research firms recently issued reports on CME. Deutsche Bank upped their price target on shares of CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a report on Friday, August 9th. Citigroup increased their target price on shares of CME Group from $220.00 to $240.00 and gave the stock a “buy” rating in a report on Monday, October 21st. Wells Fargo & Co increased their target price on shares of CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a report on Wednesday, July 3rd. BidaskClub cut shares of CME Group from a “buy” rating to a “hold” rating in a report on Friday, October 18th. Finally, Oppenheimer assumed coverage on shares of CME Group in a report on Monday, September 16th. They set an “outperform” rating and a $234.00 target price on the stock. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and six have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $203.14.

In other news, insider Sean Tully sold 7,200 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $223.13, for a total transaction of $1,606,536.00. Following the completion of the transaction, the insider now owns 19,923 shares in the company, valued at $4,445,418.99. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Howard J. Siegel sold 5,000 shares of the company’s stock in a transaction dated Friday, August 2nd. The stock was sold at an average price of $205.00, for a total transaction of $1,025,000.00. Following the transaction, the director now owns 80,382 shares of the company’s stock, valued at approximately $16,478,310. The disclosure for this sale can be found here. Insiders have sold 57,126 shares of company stock valued at $11,752,684 in the last 90 days. Insiders own 1.20% of the company’s stock.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Article: Why are trading ranges significant?

Earnings History for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.